BioNeutra Global Statistics
BioNeutra Global (BGA) Stock Statistics & Valuation Metrics
Total Valuation
BioNeutra Global has a market cap or net worth of CAD 1.39M. The enterprise value is CAD 6.91T.
- Market Cap
- CAD 1.39M
- Enterprise Value
- CAD 6.91T
Share Statistics
BioNeutra Global has 46,448,788 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,448,788
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BioNeutra Global’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, BioNeutra Global had revenue of ― and earned 1.08M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 9.22M
- Operating Income
- 2.72M
- Pretax Income
- ―
- Net Income
- 1.08M
- EBITDA
- 3.81M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 1.36
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
BioNeutra Global upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Balance Sheet
BioNeutra Global has ― in cash and marketable securities with CAD 7.19M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- CAD 7.19M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for BioNeutra Global is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

